Encyclopedia of Signaling Molecules

2012 Edition
| Editors: Sangdun Choi

Ryanodine Receptor (RyR)

Reference work entry
DOI: https://doi.org/10.1007/978-1-4419-0461-4_99

Synonyms

Historical Background

The contraction of cardiac and skeletal muscles requires the release of Ca2+ from the sarcoplasmic reticulum (SR) through specialized membrane proteins. The ion channels responsible for the release were not identified until the late 1980s. Ryanodine is an alkaloid found in the South American plant Ryania speciosa, and has insecticidal activity. This compound was found to bind to the elusive Ca2+ release channel, which was subsequently named the Ryanodine Receptor (RyR) (Meissner 1986). Early biochemical evidence first showed that the channel exists as a homotetramer, with each monomer having a mass of ∼550 kDa. This makes RyRs the largest known ion channels at ∼2.2 MDa (Lai et al. 1988). They were shown to be located in the SR with a “foot” region that spans the gap between the transverse tubule and the SR. Work on...

This is a preview of subscription content, log in to check access.

References

  1. Ahern GP, Junankar PR, Dulhunty AF. Subconductance states in single-channel activity of skeletal muscle ryanodine receptors after removal of FKBP12. Biophys J. 1997;72(1):146–62.PubMedCrossRefGoogle Scholar
  2. Balschun D, Wolfer DP, Bertocchini F, Barone V, Conti A, Zuschratter W, et al. Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning. EMBO J. 1999;18(19):5264–73.PubMedCrossRefGoogle Scholar
  3. Bers DM. Macromolecular complexes regulating cardiac ryanodine receptor function. J Mol Cell Cardiol. 2004;37(2):417–29.PubMedCrossRefGoogle Scholar
  4. Betzenhauser MJ, Marks AR. Ryanodine receptor channelopathies. Pflugers Arch. 2010;460(2):467–80.PubMedCrossRefGoogle Scholar
  5. Block BA, Imagawa T, Campbell KP, Franzini-Armstrong C. Structural evidence for direct interaction between the molecular components of the transverse tubule/sarcoplasmic reticulum junction in skeletal muscle. J Cell Biol. 1988;107(6 Pt 2):2587–600.PubMedCrossRefGoogle Scholar
  6. Gyorke S, Terentyev D. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease. Cardiovasc Res. 2008;77(2):245–55.PubMedCrossRefGoogle Scholar
  7. Hakamata Y, Nakai J, Takeshima H, Imoto K. Primary structure and distribution of a novel ryanodine receptor/calcium release channel from rabbit brain. FEBS Lett. 1992;312(2–3):229–35.PubMedCrossRefGoogle Scholar
  8. Jiang D, Xiao B, Yang D, Wang R, Choi P, Zhang L, et al. RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR). Proc Natl Acad Sci U S A. 2004;101(35):13062–7.PubMedCrossRefGoogle Scholar
  9. Kushnir A, Marks AR. The ryanodine receptor in cardiac physiology and disease. Adv Pharmacol. 2010;59:1–30.PubMedCrossRefGoogle Scholar
  10. Lai FA, Erickson HP, Rousseau E, Liu QY, Meissner G. Purification and reconstitution of the calcium release channel from skeletal muscle. Nature. 1988;331(6154):315–9.PubMedCrossRefGoogle Scholar
  11. Lai FA, Misra M, Xu L, Smith HA, Meissner G. The ryanodine receptor-Ca2+ release channel complex of skeletal muscle sarcoplasmic reticulum. Evidence for a cooperatively coupled, negatively charged homotetramer. J Biol Chem. 1989;264(28):16776–85.PubMedGoogle Scholar
  12. Ludtke SJ, Serysheva II, Hamilton SL, Chiu W. The pore structure of the closed RyR1 channel. Structure. 2005;13(8):1203–11.PubMedCrossRefGoogle Scholar
  13. Meissner G. Ryanodine activation and inhibition of the Ca2+ release channel of sarcoplasmic reticulum. J Biol Chem. 1986;261(14):6300–6.PubMedGoogle Scholar
  14. Otsu K, Willard HF, Khanna VK, Zorzato F, Green NM, MacLennan DH. Molecular cloning of cDNA encoding the Ca2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J Biol Chem. 1990;265(23):13472–83.PubMedGoogle Scholar
  15. Samso M, Feng W, Pessah IN, Allen PD. Coordinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating. PLoS Biol. 2009;7(4):e85.PubMedCrossRefGoogle Scholar
  16. Takeshima H, Nishimura S, Matsumoto T, Ishida H, Kangawa K, Minamino N, et al. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature. 1989;339(6224):439–45.PubMedCrossRefGoogle Scholar
  17. Takeshima H, Iino M, Takekura H, Nishi M, Kuno J, Minowa O, et al. Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature. 1994;369(6481):556–9.PubMedCrossRefGoogle Scholar
  18. Takeshima H, Komazaki S, Hirose K, Nishi M, Noda T, Iino M. Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2. EMBO J. 1998;17(12):3309–16.PubMedCrossRefGoogle Scholar
  19. Tanabe T, Beam KG, Adams BA, Niidome T, Numa S. Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature. 1990;346(6284):567–9.PubMedCrossRefGoogle Scholar
  20. Tung CC, Lobo PA, Kimlicka L, Van Petegem F. The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule. Nature. 2010;468(7323):585–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Biochemistry and Molecular BiologyUniversity of British ColumbiaVancouverCanada